Colchicine Indicated for the Prevention of Atherosclerotic Cardiovascular Events
By Peter A. McCullough, MD, MPH It rare that enough research is done on an old drug to win a new regulatory indication. In 2023, oral colchicine was FDA approved for the prevention of atherosclerotic cardiovascular events (myocardial infarction, stroke, coronary revascularization, and cardiovascular death). Here is some more information on this medication from the […]
Discuss on Nostr!
Nostr Note ID note1k5jvxmwgz6hjsm859m9hlhtjzvp8sfxx38p043xmp4r5utxwwxks0wyzjj Open on Primal.net Open on Snort.social Open on Iris.to Open on Coracle.social
New to Nostr?
Create an account now & join the conversation!
Promote it on DissentWatch!
- To advertise this post for $0.02 per visit send bitcoins to the address below
- The post will be promoted daily via social media & our "Featured News" display in multiple places
- You can add more anytime
- Ranking order in the Featured News box is based on the balance remaining
Received: 0 mBTC (0.00 USD)
Spent: 0 mBTC (0.00 USD)
Balance: 0 mBTC (0.00 USD)
The amounts above may be lagging behind. If you just sent a payment click below to get more up to date results and push the post to the "Featured News" box faster.